Levetiracetam

A second generation antiepileptic compound used to prevent convulsions in a variety of settings binds the synaptic vesicle protein SV2A (pIC₅₀ = 5.7), presumably altering vesicle exocytosis alters the metabolism and turnover of GABA.

A second generation antiepileptic compound used to prevent convulsions in a variety of settings binds the synaptic vesicle protein SV2A (pIC₅₀ = 5.7), presumably altering vesicle exocytosis alters the metabolism and turnover of GABA.

A second generation antiepileptic compound used to prevent convulsions in a variety of settings binds the synaptic vesicle protein SV2A (pIC₅₀ = 5.7), presumably altering vesicle exocytosis alters the metabolism and turnover of GABA.

A second generation antiepileptic compound used to prevent convulsions in a variety of settings binds the synaptic vesicle protein SV2A (pIC₅₀ = 5.7), presumably altering vesicle exocytosis alters the metabolism and turnover of GABA.

Levetiracetam-d3 is a labeled (S)-enantiomer of the ethyl analog of Piracetam

Levetiracetam -d6 (ring-d6) can be used as internal standard for the determination of Levetiracetam content in whole blood .

An internal standard suitable for levetiracetam GC/MS or LC/MS testing or isotope dilution methods in forensic analysis, clinical toxicology, pain prescription monitoring, or urine drug testing. Levetiracetam, sold under the trade name Keppra

Suitable uses for this certified solution standard include as an internal standard for quantitation of levetiracetam levels in biological matrices such as urine or isotope dilution methods by LC/MS or GC/MS for clinical toxicology, urine drug

A certified Snap-N-Spike &#174 solution applicable for use in levetiracetam testing methods by LC/MS or GC/MS for applications in clinical toxicology, medication monitoring, urine drug testing, pharmaceutical research, or forensic analysis.

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

LEVOCETIRIZINE DIHYDROCHLORIDE EUROPEAN PHARMACOPOEIA (EP) REFERENCE STANDARD